BeStock  
Stocks › Biotechnology › MRVI

Maravai LifeSciences MRVI

US equityMarket cap rank #3127Biotechnology
$6.98 −$0.21 (-2.92%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.98 0.00%
Open$7.06
Prev close$7.19
Day range$6.91 – $7.17
Volume1.79M
Market cap$1.04B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership103.1%+3.64 pts vs. prior quarter
Institutions holding229+18 vs. prior quarter
Insider trades (recent)27 buys / 23 sellsNet buying
Short interest9.43% of floatDays to cover 6.8 · as of 30 Oct 2026
Short-sale volume share21.0%5-day average of daily volume

Short-sale volume as % of daily volume

11%18%25%32%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$713.6K (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

+$1.6MSuper−$905.5KBig−$3.4MMid−$170.4KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 36.3% of shares outstanding.

Largest holders

  • GTCR LLC13.50%
  • BlackRock7.08%
  • Braidwell LP5.83%
  • Millennium Management LLC5.21%
  • 12 West Capital Management LP4.73%
  • FMR4.62%
  • Vanguard Capital Management, LLC3.52%
  • Ophir Asset Management Pty Ltd3.23%

By investor type

  • Mutual Fund51.02%
  • Hedge Fund29.96%
  • VC/PE Fund13.50%
  • Public Company3.56%
  • Individual/Insider3.55%
  • Private Company2.51%
  • Insurance Company1.54%
  • Sovereign Wealth Fund0.39%

Reported short interest has risen from 6.30% to 9.43% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
First Trust Advisors L.P. Mutual Fund 2026/Q3 +1,422,710 1.0%
FMR Mutual Fund 2026/Q3 +6,866,621 4.6%
Federated Hermes, Inc. Mutual Fund 2026/Q3 +1,094,265 0.7%
Morgan Stanley Public Company 2026/Q3 +802,781 1.8%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +802,781 1.8%
BNP Paribas Financial Markets SNC Private Company 2026/Q3 +620,443 0.9%
BlackRock Mutual Fund 2026/Q3 +591,370 7.1%
Millennium Management LLC Hedge Fund 2026/Q3 +1,264,929 5.2%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +2,267,077 1.5%
Ophir Asset Management Pty Ltd Mutual Fund 2026/Q3 +4,826,698 3.2%
Deutsche Asset & Wealth Management Mutual Fund 2026/Q3 +3,446,672 2.9%
Teachers Insurance and Annuity Association-College Retirement Equities Fund Mutual Fund 2026/Q3 +2,590,915 1.9%
PGIM, Inc. Mutual Fund 2026/Q3 +1,806,984 1.2%
Hillsdale Investment Management Inc. Mutual Fund 2026/Q3 +1,682,878 1.1%
Arrowstreet Capital, Limited Partnership Mutual Fund 2026/Q3 +1,513,606 1.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
8 Nov 2026 Bernd Brust Chief Executive Officer Sale to Issuer -29,250 $7.52 913,964
29 Oct 2026 Rajesh Asorpota EVP & Chief Financial Officer Sale to Issuer -5,466 $8.46 134,777
7 Oct 2026 Bernd Brust Chief Executive Officer Sale to Issuer -29,250 $7.43 887,659
29 Sep 2026 Rajesh Asorpota EVP & Chief Financial Officer Sale to Issuer -5,465 $7.65 126,354
7 Sep 2026 Bernd Brust Chief Executive Officer Sale to Issuer -29,250 $7.32 861,353
30 Aug 2026 Rajesh Asorpota EVP & Chief Financial Officer Sale to Issuer -5,465 $7.68 117,930
9 Aug 2026 Bernd Brust Chief Executive Officer Sale to Issuer -29,250 $6.23 835,048
29 Jul 2026 Rajesh Asorpota EVP & Chief Financial Officer Sale to Issuer -5,465 $6.59 109,507
7 Jul 2026 Bernd Brust Chief Executive Officer Sale to Issuer -29,250 $5.92 808,742
29 Jun 2026 Rajesh Asorpota EVP & Chief Financial Officer Sale to Issuer -65,584 $6.39 101,083
9 Jun 2026 Kurt Oreshack General Counsel Intent to Sell (Form 144) -25,000 $5.10 –
9 Jun 2026 Kurt Oreshack General Counsel Automatic Disposition -50,000 $5.10 138,528
8 Jun 2026 Gregory Lucier Independent Director Other Acquisition +46,293 – 264,907
8 Jun 2026 Gregory Lucier Independent Director Other Disposition -46,293 – 264,907
8 Jun 2026 Kurt Oreshack General Counsel Intent to Sell (Form 144) -25,000 $5.06 –
7 Jun 2026 Bernd Brust Chief Executive Officer Sale to Issuer -351,001 $5.02 782,437
25 May 2026 John DeFord Independent Director Other Acquisition +46,293 – 56,927
25 May 2026 Constantine Mihas Non-Independent Director Other Acquisition +46,293 – 46,293
25 May 2026 Sean Cunningham Non-Independent Director Other Acquisition +46,293 – 46,293
25 May 2026 Gregory Lucier Independent Director Other Acquisition +46,293 – 46,293

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 14,053,895 9.4% 6.8
15 Oct 2026 13,348,935 9.0% 4.5
30 Sep 2026 13,826,066 9.3% 5.9
15 Sep 2026 12,372,302 8.3% 4.7
31 Aug 2026 10,963,180 7.4% 1.7
14 Aug 2026 9,382,604 6.3% 4.6

Discussion

No comments yet — be the first to weigh in on MRVI.

Sign in to join the discussion.

Scroll to Top